(c) Correlations within the placebo group after the 12-week intervention (N=45)
| Age | Illness duration | Height | Weight | Waist | Hip | BMI | W/H ratio | FG | 2h-PG | HbA1c | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | 1 | ||||||||||
| Duration of Illness | 0.023 | 1 | |||||||||
| Height | 0.092 | 0.07 | |||||||||
| Weight | 0.059 | -0.112 | .642∗∗ | 1 | |||||||
| Waist | 0.066 | -0.257 | .353∗ | .874∗∗ | 1 | ||||||
| Hip | 0.088 | -0.085 | .380∗∗ | .872∗∗ | .850∗∗ | 1 | |||||
| BMI | 0.012 | -0.197 | 0.147 | .849∗∗ | .879∗∗ | .872∗∗ | 1 | ||||
| W/H ratio | 0.007 | -.380∗∗ | 0.157 | .500∗∗ | .754∗∗ | .297∗ | .518∗∗ | 1 | |||
| Fasting glucose | -0.085 | .305∗ | 0.001 | 0.001 | 0.049 | 0.078 | -0.004 | -0.052 | 1 | ||
| 2h-PG | .345∗ | 0.217 | 0.254 | .375∗ | .337∗ | .445∗∗ | .316∗ | 0.044 | 0.26 | 1 | |
| HbA1c | 0.233 | 0.211 | -0.089 | -0.011 | 0.054 | 0.1 | 0.032 | -0.059 | .595∗∗ | .431∗∗ | 1 |
∗, Pearson correlation was significant at the 0.05 level (2-tailed).
∗∗, Pearson correlation was significant at the 0.01 level (2-tailed).